The Penny Price Pharmacy Toolkit: How Local Government Can Leverage the Federal 340B Program to Lower Out-of-Pocket Prescription Drug Costs
August 2025 — This toolkit explains how local lawmakers can leverage an obscure federal drug-pricing program, called 340B, that allows safety-net health care providers — often publicly owned — to purchase prescription drugs at special low prices, including the underlying legal authority.
Taking On Power Buyers: Expedient, High-Impact Enforcement of Federal and California Price Discrimination Laws
July 25, 2025 — This document outlines potential expedient, high-impact paths for legal action by a disfavored retailer or retailer association against a favored buyer for certain forms of price discrimination under federal and California law.
Morgan’s Monopoly Digest – July 2025
July, 2025 — July version of Economic Liberties' monthly newsletter that covers the latest with the federal antitrust agencies — the Federal Trade Commission and the Department of Justice's Antitrust Division — and other big developments in competition policy.
Written Comments to the FTC in Response to Synopsys-Ansys Consent Decree
July 7, 2025 — Economic Liberties submitted a comment letter in response to the FTC's request for comments regarding the Consent Agreement proposed by the Commission to avoid filing a lawsuit to challenge an anticompetitive $35 billion merger between Synopsys, Inc. and ANSYS, Inc.
Morgan’s Monopoly Digest – June 2025
June, 2025 — June version of Economic Liberties' monthly newsletter that covers the latest with the federal antitrust agencies — the Federal Trade Commission and the Department of Justice's Antitrust Division — and other big developments in competition policy.
Seven Key Questions About the Potential Release of Fannie Mae and Freddie Mac from Government Conservatorship
May 29, 2025 —This issue brief provides background on how Fannie Mae and Freddie Mac, and identifies seven key questions that will determine how a possible release from conservatorship could affect consumers and America’s mortgage and financial markets.